Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (41-50 of 349) with videos related to

Pageof 35
Sort By:
Statistics in Medicine|February 15, 2003
Adjusting treatment comparisons to account for non-randomized interventions: an example from an angina trialIan R White, James Carpenter, Stuart J Pocock, et al.
American Heart Journal|December 3, 2014
Individualizing treatment choices using quantitative methodsStuart J Pocock, Gregg W Stone, Roxana Mehran, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Impact of missing data due to selective dropouts in cohort studies and clinical trialsGiota Touloumi, Stuart J Pocock, Abdel G Babiker, et al.
European Heart Journal|September 9, 2011
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical prioritiesStuart J Pocock, Cono A Ariti, Timothy J Collier, et al.
Statistics in Medicine|January 12, 2016
Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty modelJennifer K Rogers, Alex Yaroshinsky, Stuart J Pocock, et al.
Statistics in Medicine|September 27, 2002
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problemsStuart J Pocock, Susan E Assmann, Laura E Enos, et al.
Current Medical Research and Opinion|September 12, 2015
Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patientsJennifer K Rogers, Adrian Kielhorn, Jeffrey S Borer, et al.
Nature Reviews. Cardiology|February 5, 2016
The rise, fall, and possible resurrection of renal denervationRajiv Gulati, Claire E Raphael, Manuela Negoita, et al.
Journal of the American College of Cardiology|August 1, 2015
10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized TrialRobert A Henderson, Christopher Jarvis, Tim Clayton, et al.
Clinical Cardiology|April 6, 2021
Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trialJoão Pedro Ferreira, John Gregson, Michael Böhm, et al.
Pageof 35

Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
Statistics in Medicine|February 15, 2003
Adjusting treatment comparisons to account for non-randomized interventions: an example from an angina trialIan R White, James Carpenter, Stuart J Pocock, et al.
American Heart Journal|December 3, 2014
Individualizing treatment choices using quantitative methodsStuart J Pocock, Gregg W Stone, Roxana Mehran, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Impact of missing data due to selective dropouts in cohort studies and clinical trialsGiota Touloumi, Stuart J Pocock, Abdel G Babiker, et al.
European Heart Journal|September 9, 2011
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical prioritiesStuart J Pocock, Cono A Ariti, Timothy J Collier, et al.
Statistics in Medicine|January 12, 2016
Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty modelJennifer K Rogers, Alex Yaroshinsky, Stuart J Pocock, et al.
Statistics in Medicine|September 27, 2002
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problemsStuart J Pocock, Susan E Assmann, Laura E Enos, et al.
Current Medical Research and Opinion|September 12, 2015
Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patientsJennifer K Rogers, Adrian Kielhorn, Jeffrey S Borer, et al.
Nature Reviews. Cardiology|February 5, 2016
The rise, fall, and possible resurrection of renal denervationRajiv Gulati, Claire E Raphael, Manuela Negoita, et al.
Journal of the American College of Cardiology|August 1, 2015
10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome: The British Heart Foundation RITA-3 Randomized TrialRobert A Henderson, Christopher Jarvis, Tim Clayton, et al.
Clinical Cardiology|April 6, 2021
Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trialJoão Pedro Ferreira, John Gregson, Michael Böhm, et al.
Pageof 35